Genesis Therapeutics
Bing Han, CPA, currently serves as a Senior Accountant at Genesis Therapeutics since September 2022. Prior experience includes roles as an Assurance Associate at RSM US LLP from October 2021 to September 2022 and as a Staff Accountant at CTK Biotech, Inc. from June 2014 to September 2021, where notable contributions included financial audits and due diligence for M&A transactions, earning the Above and Beyond award in 2020. Additional experience encompasses work as a Bookkeeper & Administrative Assistant, managing financial transactions, and as a Business Analyst at Heart to Heart, where coordination of import/export logistics and inventory optimization were key responsibilities. Bing Han holds a Master's degree in International Business from the University of Florida and a Bachelor's degree in Economics from UC San Diego.
This person is not in any offices
Genesis Therapeutics
3 followers
Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies.